1. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol, 2008; 142(6): 859-76
2. Ball S. Diamond Blackfan anemia. American Society of Hematology Education Program 2011; 2011: 487-91
3. Orfali KA, Ohene-Abuakwa Y, Ball SE. Diamond Blackfan anaemia in the UK: clinical and genetic heterogeneuty. Br J Haematol, 2004; 125(2): 243-52
4. Lipton JM, Atsidaftos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: An update from the Diamond-Blackfan Anemia Registry. Pediatr Blood & Cancer, 2006; 46: 558-64
5. Jaako P, Flygare J, Karisson S. Diamond-Blackfan anemia: pathogenesis, management and development of future therapies. Hematology education: the education program for the annual congress of the European Hematology Association, 2013; 7:101-8
6. Narla A, Ebert BL Ribosomopathies: human disorders of ribosome dysfunction. Blood, 2010; 115(16): 3196-205
7. Fumagalli S, Thomas G. The role of p53 in ribosomopathies. Semin Hematol, 2011; 48(2): 97-105
8. Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell, 2009; 16(5): 369-77
9. Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C, et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood, 2011; 117(9):2567-76
10. Horn HF, Vousden KH. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene, 2008; 27(44): 5774-84
11. Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene, 2007; 26(35): 5029-37
12. Fumagalli S, Ivanenkov VV, Teng T, Thomas G. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev, 2012; 26(10):1028-40
13. Gazda HT, Kho AT, Sanoudou D, Zaucha JM, Kohane IS, Sieff CA, et al. Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells, 2006; 24(9):2034-44
14. Badhai J, Frojmark AS, J Davey E, Schuster J, Dahl N. Ribosomal protein S19 and S24 insufficiency causes distinct cell cycle defects in Diamond-Blackfan anemia. Biochim Biophys Acta, 2009; 1792(10):1036-42
15. Moniz H, Gastou M, Leblanc T., Hurtaud C., Cretien A. Lёcluse Y., et al. Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death Dis, 2012; 3:e356
16. Horos R, Ijspeert H, Pospisilova D, Sendtner R., Andrieu-Soler C, Taskesen E, et al. Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood, 2012; 119(1):262-72
17. Horos R, von Lindern M. Molecular mechanisms of pathology and treatment in Diamond Blackfan anaemia. Br J Haematol, 2012; 159(5): 514-27
18. Da Costa L, O’Donohue MF, van Dooijeweert B, Albrecht K, Unal S, Ramenghi U, et al. (2018) Molecular approaches to diagnose Diamond-Blackfan anemia: the EuroDBA experience. Eur J Med Gen, 2018; 61(11): 664-673
19. Boria I, Garelli E, Gazda HT, Aspesi A, Quarello P, Pavesi E, Ferrante D, Meerpohl JJ, Kartal M, Da Costa L, Proust A, Leblanc T, Simansour M, Dahl N, Frojmark AS, Pospisilova D, Cmejla R, Beggs AH, Sheen MR, Landowski M, Buros CM, Clinton CM, Dobson LJ, Vlachos A, Atsidaftos E, Lipton JM, Ellis SR, Ramenghi U, Dianzani I. The ribosomal basis of Diamond-Blackfan anemia: mutation and database update. Hum Mutat, 2010: 31:1269-1279
20. Vlachos A, Dahl N, Dianzani I, Lipton JM: Clinical utility gene card for: Diamond Blackfan anemia-update 2013. Euro J Hum Genet, doi: 10.1038/jejhg.2013.34
21. Smetanina NS, Mersiyanova IV, Kurnikova MA, Ovsyannikova GS, Hachatryan LA, Bobrynina VO, Maschan MA, Novichkova GA, Lipton JM, Maschan AA. Clinical and Genomic Heterogeneity of Diamond-Blackfan Anemia in the Russian Federation. Pediat Blood & Cancer, 2015; 62(9): 1597-1600
22. Sankaran VG, Ghazvinian R, Do R, Thiru P, Vergilio JA, Beggs AH, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest, 2012; 122(7):2439-43
23. Rey MA, Duffy SP, Brown JK, Kennedy JA, Dick JE, Dror Y, et al. Enhanced alternative splicing of the FLVCR1 gene in Diamond-Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis. Haematologica, 2008; 93(11): 1617-26
24. Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol, 2018; 38: 569- 578
25. Kynaston J.A., West N.C., Reid M.M. A regional experience of red cell aplasia. Eur J Pediatr, 1993; 152: 306-308
26. Ball S.E., McGuckin C.P., Jenkins G., Gordon-Smith E.C. Diamond-Blackfan anaemia in the U.K.: Analysis of 80 cases from a 20-year birth cohort. Br J Haematol, 1996; 94:645653
27. Campagnoli M.F., Garelli E., Quarello P., Carando A., Varotto S., Nobili B., Longoni D., Pecile V., Zecca M., Dufour C. Molecular basis of Diamond-Blackfan anemia: New findings from the Italian registry and a review of the literature. Haematologica, 2004;89:480-9
28. Willig T.N., Niemeyer C.M., Leblanc T., Tiemann C., Robert A., Budde J., Lambiliotte A., Kohne E., Souillet G., Eber S. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Sociёtё d'l lematologie et d'lmmunologie Pёdiatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI) Pediatr. Res.1999;46:553-61